Share-Based Expense (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compensation Related Costs [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allocation of share-based compensation expense |
Employee Stock Options
No employee stock option awards to purchase shares of common stock were granted or exercised during the three months ended March 31, 2026 and 2025. During the three months ended March 31, 2026 and 2025, options to purchase shares of common stock and shares of common stock expired, respectively. The Company recognized a total of approximately $ and $ of share-based expense related to employee stock options during each of the three months ended March 31, 2026 and 2025.
Non-Employee Stock Options
There were non-employee options outstanding as of both March 31, 2026 and December 31, 2025. There were non-employee stock options granted or exercised during the three months ended March 31, 2026 and 2025. No non-employee stock option grants expired during the three months ended March 31, 2026 and 2025. The Company did t recognize any share-based expense related to non-employee stock options during the three months ended March 31, 2026 and 2025. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||